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Abstract: Brucella serostatus was evaluated in 3189 muskoxen sampled between 1989 and 2016 from various
locations of the Canadian Arctic archipelago and mainland, near the communities of Sachs Harbour and
Ulukhaktok, Northwest Territories, and Cambridge Bay and Kugluktuk, Nunavut. Brucella antibodies were
found only in muskoxen sampled around Cambridge Bay, both on southern Victoria Island and on the
adjacent mainland (Kent Peninsula). Consistent with participatory epidemiology data documented from local
harvesters describing increased Brucella-like syndromes (swollen joints and lameness) and a decreased pro-
portion of juveniles, the apparent Brucella seroprevalence in the sampled muskoxen of the Cambridge Bay area
increased from 0.9% (95% CI 0.3–2.1) in the period of 1989–2001 to 5.6% (95% CI 3.3–8.9) in 2010–2016. The
zoonotic bacteria Brucella suis biovar 4 was also cultured from tissues of muskoxen sampled on Victoria Island
near Ulukhaktok in 1996 (n = 1) and Cambridge Bay in 1998, 2014, and 2016 (n = 3). Overall, our data
demonstrate that B. suis biovar 4 is found in muskoxen that are harvested for food and by guided hunts on
Victoria Island and Kent Peninsula, adding an important public health dimension to this study. Robust
participatory epidemiology data on muskox health and diseases greatly enhanced the interpretation of our
Cambridge Bay data and, combined with the serological and microbiological data, provide compelling evidence
that the prevalence of B. suis biovar 4 has increased in this area since the late 1990s. This study enhances the
available knowledge on Brucella exposure and infection in muskoxen and provides an example of how scientific
knowledge and local knowledge can work together to better understand disease status in wildlife.
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INTRODUCTION
Brucella suis biovar 4 is a Gram-negative coccobacillus that
is the etiologic agent of rangiferine brucellosis, a disease that
is endemic in many barren-ground caribou (Rangifer
tarandus groenlandicus) and reindeer (Rangifer tarandus
tarandus) populations around the Arctic (Rausch and
Huntley 1978; Tessaro and Forbes 1986; Thorne 2001;
Godfroid et al. 2013, 2014; Carlsson et al. 2019). Rangiferine
brucellosis is an important zoonosis that can result in a
severe and highly debilitating disease in humans (Godfroid
2002). For humans, exposure to B. suis biovar 4 occurs
through direct contact with infected animals either during
butchering or through the consumption of undercooked
meat, viscera, and bone marrow, as well as unpasteurized
milk (OIE 2016). Although the current prevalence of B. suis
biovar 4 in people is unknown, historic data for Alaska and
Canada’s Arctic highlight that rangiferine brucellosis has
occurred among northern peoples who consumed caribou
(Meyer 1966; Huntley et al. 1963; Chan et al. 1989; Tessaro
and Forbes 1986; Forbes 1991; Ferguson 1997). Rangiferine
brucellosis continues to be an important public health
concern in the Arctic, a place where many people rely on
harvesting of caribou, muskoxen (Ovibos moschatus) and
other wildlife for subsistence (CINE 2005; Meakin and
Kurvits 2009; Tomaselli et al. 2018a). A human case of
Brucella suis infection was recently documented in
Ulukhaktok (Turvey et al. 2017), community of northern
Canada included in our study area.
In caribou and reindeer, B. suis biovar 4 can cause
granulomatous lesions primarily in bones, joints, and
reproductive organs, leading to reproductive failure and
increased susceptibility to predation (Thorne 2001). Evi-
dence of B. suis biovar 4 exposure has been found in
numerous carnivore species which prey on caribou (Nei-
land 1975; Zarnke et al. 2006); and natural infection with B.
suis biovar 4 has been sporadically described in moose
(Alces alces) and muskoxen that are sympatric with caribou
(Honour and Hickling 1993; Edmonds et al. 1999; Gates
et al. 1984; Forbes 1991; Tomaselli et al. 2016). More re-
cently, within the scope of a participatory epidemiology
study on muskox health and diseases in the community of
Cambridge Bay (Victoria Island, Nunavut, Canada), har-
vesters reported increasingly observing signs of lameness
and swollen joints in muskoxen (Tomaselli et al. 2018b).
Additional hunter observations for the same time period
included the decline of the local muskox population and a
decreased proportion of juvenile muskoxen (Tomaselli
et al. 2018b).
In response to these observations, as well as the
detection of a subclinical case of B. suis biovar 4 in a
hunter-killed muskox in 2014 (Tomaselli et al. 2016), we
initiated a study to determine past and current exposure to,
and occurrence of, B. suis biovar 4 in muskoxen in the
western Canadian Arctic. This study is particularly relevant
given that muskoxen are an important source of food and
revenue for northern communities of Canada (Gunn and
Adamczewski 2003; Tomaselli et al. 2018a; Cuyler et al.
2019).
We drew on a large sample size of archived sera and
analyses from harvested and live-captured muskoxen from
several locations of the western Canadian Arctic as well as
‘contemporary’ samples collected through our ongoing
hunter-based muskox health sampling program in Cam-
bridge Bay and Kugluktuk (Nunavut, Canada) (see To-
maselli 2018). The aims of this study were to (i) investigate
over time and space the Brucella status of muskoxen using
serology and opportunistic postmortem sampling, and (ii)
to ‘triangulate’ this knowledge by combining and inter-
preting it with the available local knowledge on muskox
health and diseases. This process of corroborating data
using independent methods and knowledge sources is
commonly used in participatory surveillance of livestock
diseases as a way to enhance reliability of assessments
(Mariner and Paskin 2000; Catley et al. 2012) and it can
also be successfully applied to the veterinary surveillance of
free-ranging wildlife populations (Tomaselli 2018).
This study increases the breadth and depth of knowl-
edge on the occurrence of brucellosis in muskoxen, in part
through the combined use of scientific knowledge and local
knowledge. The transdisciplinary approach taken for this
study is a practical example of the application of the ‘two-
eyed seeing’ principle recently advocated for wildlife health




Whole blood and/or blood-saturated filter paper (FP) strips
were collected from muskoxen that were hunter-harvested
(n = 3164), live-captured (n = 17), found dead (n = 7),
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and euthanized (n = 1) between 1989 and 2016 in various
locations of the Canadian Arctic archipelago and mainland,
near the communities of Sachs Harbour (SH, n = 1825)
and Ulukhaktok (UL, n = 405), Northwest Territories, and
Cambridge Bay (CB, n = 864) and Kugluktuk (KU,
n = 95), Nunavut (Table 1; Fig. 1). During and prior to
2012, the vast majority of the samples were collected during
commercial muskox harvests that occurred regularly on
Banks and Victoria Islands near SH, CB, and UL, whereas
near KU, samples were collected in conjunction with sub-
sistence harvests and live-captures. After 2012, the majority
of the samples were obtained through hunter-based sam-
pling programs that were organized in CB and KU in
association with outfitted hunts and subsistence harvests. A
small number of additional samples were collected during
opportunistic disease investigations near CB. Near KU, the
collection of samples occurred on the mainland near the
community, except for 24 and three muskoxen that were
sampled on the southwest corner of Victoria Island (Lady
Franklin Point) in 2010 and 2015, respectively. While the
majority of the muskoxen sampled near CB were harvested
on Victoria Island, 11 of the muskoxen sampled in 2016
were harvested on Kent Peninsula, on the adjacent main-
land.
For the hunter-harvested muskoxen and the euthanized
muskox, whole blood and/or blood-saturated FP strips were
collected immediately after the animals were shot. Serum or
plasma was obtained by collecting venous blood (jugular or
femoral) into a Vacutainer tube with (i.e., ethylenedi-
aminetetraacetic acid, EDTA) or without anticoagulant (for
plasma and serum, respectively). In some cases, sterile fal-
con tubes were also used for the collection of whole blood.
Filter paper samples were obtained by saturating the full
length of Nobuto filter strips (Advantec MFS Inc., Dublin,
California, USA) in venous blood as described by Curry
et al. (2011). Immediately after collection, blood-saturated
FP strips for each animal were placed into an antimicrobial-
lined envelope (Quality Park, St. Paul, Minnesota, USA),
except for the 19 FP strips collected in SH in 2008, which
were stored in regular envelopes without antimicrobial-
lining. For live-captured muskoxen, serum samples were
obtained by collecting venous blood via jugular venipunc-
ture into Vacutainer tubes after animals were chemically
immobilized (Harms et al. 2012). Finally, for the seven
muskoxen that were found dead near CB in 2015, blood
samples (FP strips and/or Vacutainer tubes) were obtained
from any site available for collection (i.e., heart, neck, leg).
The times of death for these animals were estimated to be a
few to several months prior to sample collection, and they
had remained on the tundra under ambient temperatures
below 0C until sampled. Although they had remained
‘cool’, the carcasses were in varying states of decomposition
and scavenging, thus the blood collection site depended on
the state of carcass preservation.
After field collection, tube-collected blood was cen-
trifuged for approximately 10 min at standard speed (i.e.,
G-Force and RPM as recommended by centrifuge manu-
facturer) and aliquots of serum or plasma were kept at -
20C until tested, while blood-saturated FP samples were
stored at - 20C or air-dried overnight. All FPs were re-
ceived at Faculty of Veterinary Medicine, University of
Calgary (Alberta, Canada) and were stored at - 20C or
air-dried until testing (Curry et al. 2011, Curry et al.
2014a). Prior to testing, any frozen FP strips were also air-
dried overnight at room temperature (Curry et al. 2011).
One fully saturated FP strip for each dried sample was then
re-suspended in phosphate-buffered solution following the
protocol described by Curry et al. (2011) to obtain a FP
elution estimated at 1:10 serum concentration. These were
stored at - 20C until antibody analysis.
‘Historical’ Brucella Antibody Testing: BPAT and Confirma-
tory Ancillary Tests
A set of sera included in this study (CB 1989–2001; KU
1991; UL 1994–1999; SH 1999–2012) had been tested
shortly after the respective times of collection for Brucella
antibodies using the buffered plate agglutination test
(BPAT) for screening as described by the Office Interna-
tional Des Epizooties (OIE 1996, 2016) (Table 1). Standard
tube agglutination test (STAT) (Stemshorn 1985) was
additionally used only for the CB collection of 1989. Sera
that tested positive in the screening phase were further
tested using ancillary tests: the complement fixation test
(CFT) (Stemshorn 1985), or iELISA (Nielsen et al. 1994)
and/or competitive enzyme-linked immunoassay (cELISA)
(Nielsen et al. 1996) (Table 1). Sera were considered pos-
itive for Brucella antibodies if they remained positive after
the ancillary-supplemental testing. Analyses were per-
formed shortly after sample collection at the laboratories of
the Canadian Food Inspection Agency (Brucellosis Centres
of Expertise) in Lethbridge and Ottawa (Alberta and
Ontario, Canada) except for sera collected near KU in 1991,
and CB in 1989 and 1991. These were tested at the Health
of Animals Laboratory in Saskatoon (Saskatchewan, Ca-
nada) following the same protocol.
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‘Contemporary’ Brucella Antibody Testing: A/G iELISA
The remaining sera, FP eluates and plasma samples (CB
2010–2016; KU 2010–2016) were tested for Brucella anti-
bodies with a protein A/G indirect enzyme-linked
immunoassay (A/G iELISA) (Nymo et al. 2013). Addi-
tionally, 93 BPAT-tested sera that were archived from the
SH collection 2008 (n = 34) and 2012 (n = 59) were re-
tested by A/G iELISA. Among the A/G iELISA-tested
samples, there were 29 paired serum and FP samples
(n = 20 SH 2008, n = 1 CB 2014, n = 6 CB 2015, n = 2 CB
2016). The paired serum and FP samples of the muskox
harvested in CB in 2014 are from the case described in
Tomaselli et al. (2016). The archived blood samples that
were obtained from that case were here newly tested with
the A/G iELISA. Finally, among the SH collection 2008,
there were also 28 sera that were tested by BPAT at the time
of collection and had paired FP samples that were newly
Figure 1. Area of study showing the locations where the samples were collected (line pattern fill) in proximity of the communities of Sachs
Harbour (SH) and Ulukhaktok (UL), the Northwest Territories, and Cambridge Bay (CB) and Kugluktuk (KU), Nunavut (marked with a star).
Locations of the Brucella positive muskoxen are marked with a black dot (only serology-positive blood samples), white cross (only microbiology
positive tissue samples in which Brucella suis biovar 4 was isolated), and black cross (serology-positive blood samples coupled with microbiology
positive tissue samples in which B. suis biovar 4 was isolated; with the letter a we refer to the microbiology result described in Tomaselli et al.
2016). When a georeferenced location represents more than one animal, a number indicates the sample size. For completeness, we finally
indicate with gray triangles the locations of two male muskoxen from which B. suis biovar 4 was isolated in tissue samples and that are available
in the published literature (b, Gates 1883; c, Forbes 1991).
492 M. Tomaselli et al.
tested by A/G iELISA (Table 1). Testing was performed
blindly on both BPAT-tested sera and paired samples. The
A/G iELISA testing was performed in 2017 at UiT—The
Arctic University of Norway, Research Group for Arctic
Infection Biology (Tromsø, Norway).
Serology Data Analyses and Interpretation
There is no information regarding the sensitivities and
specificities of the tests used in this study for the detection
of Brucella antibodies in muskoxen; therefore, cutoff values
derived for reindeer and caribou (Gall et al. 2001; Nymo
et al. 2013) were used. To assist with the interpretation of
the A/G iELISA results, we report the percentage of posi-
tivity of the blood samples tested relative to the caribou
bacteriology and serology-positive control (%P = [optical
density sample/optical density positive control] 9 100;
Nymo et al. 2013). We compared the average %P values of
the A/G iELISA negative and positive blood samples with
the %P of the samples that were bacteriology positive
(n = 2) and negative (n = 1). Based on tests results, we
calculated the apparent prevalence (AP) together with the
95% confidence intervals computed using the Clopper–
Pearson method (Brown et al. 2001).
Participatory epidemiology data on muskox demo-
graphics and morbidity (collectively defined as local knowl-
edge) were available only for the Cambridge Bay area (see
Tomaselli et al. 2018b) and were used to support analyses and
interpretation of the CB samples. Cambridge Bay data ob-
tained through this study were categorized into two time
periods defined based on demography trends available
through local knowledge, particularly a ‘pre-decline’ period
from the 1990s to mid-2000s, and a ‘decline’ period from
mid-2000s to the end of 2014 and onwards (Tomaselli et al.
2018b). The decline period was characterized by a major
decrease in the number of muskoxen, and particularly the
proportion of juveniles, as well as increasing observations of
muskoxen with Brucella-like clinical signs such as swollen
joints and lameness (Tomaselli et al. 2018b). The McNemar’s
test for association of paired counts was used to test whether
the Brucella seroprevalences of samples categorized in the
‘pre-decline’ and ‘decline’ periods were significantly different.
Brucella-Cultured Muskoxen: Tissue Collection
for Pathology and Microbiology Analyses
During the commercial harvests in UL in 1996, and CB in
1998, veterinarians inspected muskox carcasses and tissue
samples with lesions that had Brucella infection listed as
possible differential diagnosis were obtained from three and
eight carcasses, respectively (Table 3). Shortly after the
respective time of collection, tissue samples stored frozen
(- 20C) were submitted to the Canadian Wildlife Health
Cooperative (CWHC) (University of Saskatchewan,
Saskatoon, Canada) for further pathological and microbi-
ological testing. Results of Brucella antibody testing (i.e.,
BPAT) on serum samples are also available for 10 of those
11 ‘historical’ cases.
In 2016, gross lesions consistent with Brucella infection
were detected in two adult cows near CB (one sick cow that
was euthanized by the Wildlife Officer and one that was
harvested for subsistence). Shortly after collection, tissue
samples stored frozen (- 20C) were submitted for further
testing to the CWHC (University of Calgary) and to the
Canadian Food Inspection Agency Brucellosis National Ref-
erence Laboratory (Ottawa, Ontario, Canada). We also in-
clude here microbiology results of a previous case
summarized in Tomaselli et al. (2016) that was hunted on
Victoria Island (CB area) in 2014. Results of Brucella antibody
testing (i.e., A/G iELISA) on paired serum and FP samples are
also available for these ‘contemporary’ cases of 2014 and 2016.
RESULTS
Brucella Serology
Overall Screening: ‘Historically’ and ‘Contemporary’ Tested
Samples
Overall, the only blood samples that tested positive for
Brucella antibodies were from hunter-harvested (n = 21)
and euthanized (n = 1) muskoxen near the community of
Cambridge Bay, both on Victoria Island and on Kent
Peninsula, mainland (Table 1 and Fig. 1).
Among ‘historically’ tested samples (i.e., BPAT and
confirmatory ancillary tests), Brucella antibodies were
found by BPAT and confirmed by CFT in five CB sera
collected on Victoria Island in 1996 and 1998 (Table 1). Of
those, the CFT titers were 1/80 (n = 2), 1/160 (n = 1), and
1/640 (n = 1) for 1996 and 1/2560 (n = 1) for 1998. For SH
samples, six and two sera collected in 2008 and 2011,
respectively, were classified positive on BPAT but negative
on the confirmatory tests performed (iELISA and/or cE-
LISA) (Table 1). All other samples (SH, KU, UL) were
negative for Brucella antibodies on BPAT (Table 1).
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Among ‘contemporary’ tested samples (i.e., A/G iE-
LISA), Brucella antibodies were found only in CB blood
samples collected on Victoria Island between 2010 and
2016 (16/291) and on Kent Peninsula, mainland, in 2016
(1/11) (Table 1 and Fig. 1). All other samples (SH, KU)
tested were classified negative for Brucella antibodies on A/
G iELISA (Table 1).
Period Differences in Samples Tested from the Cambridge Bay
Area
Serology data available for the CB area were further ana-
lyzed separated into the ‘pre-decline’ and ‘decline’ periods
defined though participatory epidemiology. For muskoxen
sampled in the period 1989–2001 (‘pre-decline’; BPAT-
tested samples), the overall apparent Brucella seropreva-
lence was 0.9% (5/562, 95% CI 0.3–2.1), whereas, in the
following sampling period 2010–2016 (‘decline’; A/G iE-
LISA-tested samples), the overall apparent Brucella sero-
prevalence significantly increased to 5.6% (17/302, 95% CI
3.3–8.9; McNemar’s v2 statistic 506, degrees of freedom 1,
p value < 0.001).
Interpretation of Results from Serology Tests
To assist with the interpretation of the A/G iELISA results,
we report in Table 2 the %P of the blood samples that were
bacteriology positive (n = 2) and negative (n = 1). The %P
of the rest of the negative and positive A/G iELISA-tested
samples is also reported for comparison (Table 2).
Regarding the comparison between A/G iELISA results of
the 29 paired serum and FP samples (collected from the
same individuals), there was complete agreement on their
Brucella serostatus: 26 were seronegative and three were
positive. Finally, regarding the comparison between diag-
nostic tests, the archived sera from SH 2008 (n = 34) and
2012 (n = 59) that were negative with the BPAT at the time
of collection were also negative when retested with the A/G
iELISA; and the 28 sera from SH 2008 that were negative
with the BPAT at the time of collection had paired FP
eluates that were also negative when tested with the A/G
iELISA.
Brucella-Cultured Muskoxen
Of the 14 muskoxen that had postmortem lesions suspi-
cious of brucellosis (including the case described in To-
maselli et al. 2016), four cultured positive for B. suis biovar
4 (Table 3). All culture-positive animals were from Victoria
Island, one near UL in 1996 (a commercially-harvested
muskox) and the remaining three near CB in 1998 (a
commercially-harvested muskox), 2014 (a sport-hunted
adult male; Tomaselli et al. 2016), and 2016 (a euthanized
adult female) (Fig. 1). Brucella antibodies were not detected
Table 2. Percentage of Positivity (%P) of Muskox Sera (S), Filter Paper Eluates (FP), and Plasma (PL) that were Classified Positive or
Negative by A/G iELISA.
Sample identification Status %P
A/G iELISA B. suis biovar 4 S FP PL
Hunted male, CB 2014 Positive Positivea 37.43 40.40 n/a
Euthanized cow, CB 2016 Positive Positive 41.58 25.68 n/a
Hunted cow, CB 2016 Negative Negative 0.65 0.64 n/a
Remaining samples—positive Positive n/a 12.24 (n = 1)b 29.88 (SD 5.18; n = 12) 11.28 (SD 3.35; n = 3)
Remaining samples—negative Negative n/a 0.51 (SD 0.11; n = 115) 0.59 (SD 0.18; n = 326) 0.67 (SD 0.24; n = 52)
For each sample the %P was computed relative to the positive control used on the same plate (%P = [optical density sample/optical density positive
control] 9 100) where the positive control was from a microbiology and serology-positive caribou (Nymo et al. 2013). The first 3 samples were from
animals confirmed by microbiology as either positive or negative for infection with Brucella suis biovar 4. For the remaining samples confirmatory
microbiology was not available (n/a), thus are identified as positive or negative based on the A/G iELISA. For these samples the mean value is reported and
the standard deviation (SD) and the number of samples tested (n) are specified in parenthesis.
aTomaselli et al. (2016).
bFund-dead cow, CB 2015 (%P in paired FP sample = 36.97).
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in blood samples of Brucella culture-negative muskoxen
(Table 3). For the Brucella culture-positive muskoxen that
had coupled serology results, Brucella antibodies were de-
tected in paired sera and FP eluates that were tested with A/
G iELISA (n = 2) but were not detected in the one serum
sample that was tested with BPAT (CB 1998; Table 3).
DISCUSSION
Our results, using contemporary and archived samples and
data collected over almost 30 years, demonstrate that B.
suis biovar 4 is increasingly found in muskoxen on Victoria
Island and Kent Peninsula on the nearby mainland in the
western Canadian Arctic. In addition, for the muskoxen of
the Cambridge Bay area, serology data combined with
available participatory epidemiology data (Tomaselli et al.
2018b) provide compelling evidence that the prevalence of
B. suis biovar 4 has increased since the late 1990s. Although
Brucella antibodies were not detected in the muskoxen
sampled on Banks Island and the Kugluktuk area on the
mainland, we cannot conclude that these locations are free
of B. suis biovar 4 due to the limitations of study design
(discussed later) and in absence of participatory epidemi-
ology for triangulation. Our work confirms the importance
of archived samples for understanding disease status and
emergence in wildlife (Mörner et al. 2002; Hoberg et al.
2008; Ryser-Degiorgis 2013) and emphasizes the value of
triangulating different data sources (i.e., scientific and local
knowledge) to improve this understanding in the absence
of perfect tests and study design (Tomaselli et al. 2018b), a
common limitation when studying diseases in free-ranging
animals (e.g., Wobeser 2007; Godfroid et al. 2010; Gilbert
et al. 2013; Ryser-Degiorgis 2013). In a remote setting, such
as the Arctic, this approach of acquiring data from multiple
sources (active sampling, local knowledge, archival collec-
tions) can greatly strengthen future monitoring and
surveillance efforts for rangiferine brucellosis and beyond
(Tomaselli 2018).
Considerations for the Interpretation of Brucella
Serology Data
As typical for wildlife serological surveys, we encountered
several challenges in the interpretation of serological data.
Limitations to be considered are linked to the inability to
use a probability sampling method, changing methodolo-
Table 3. Microbiology and Serology Status of Samples (Tissues and Blood, Respectively) Collected from Muskoxen that had Gross
Lesions with Brucella Infection Listed as a Possible Differential Diagnosis.
Location Year Identified lesion Status
B. suis biovar 4 Serology
Ulukhaktok 1996 Lymphadenitis Negative Negative1
Ulukhaktok 1996 Nephritis, splenitis, lymphadenitis Positive n/a
Ulukhaktok 1996 Lymphadenitis Negative Negative1
Cambridge Bay 1998 Skin abscess Negative Negative1
Cambridge Bay 1998 Squamous cell carcinoma Negative Negative1
Cambridge Bay 1998 Lymphadenitis Negative Negative1
Cambridge Bay 1998 Lymphadenitis Positive Negative1
Cambridge Bay 1998 Fat abscess Negative Negative1
Cambridge Bay 1998 Lymphadenitis Negative Negative1
Cambridge Bay 1998 Lymphadenitis Negative Negative1
Cambridge Bay 1998 Lymphadenitis Negative Negative1
Cambridge Bay 2014 Metatarsal abscess Positivea Positive2
Cambridge Bay 2016 Bilateral abscesses in the vagina Negative Negative2
Cambridge Bay 2016 Granulomatous mastitis, endometritis, lymphadenitis, nephritis Positive Positive2
Bacteriology status of muskoxen was determined by culturing tissues with identified lesions; while serology status of muskoxen was determined by BPAT on
sera (1), A/G iELISA on paired sera and filter papers eluates (2), or was not available (n/a).
aTomaselli et al. (2016).
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gies for Brucella serology screening and, most importantly,
the lack of test validation. For example, although BPAT is
one of the tests recommended by the OIE to screen for
brucellosis in cattle with a sensitivity of 100% in this species
(OIE 2016), the sensitivity of BPAT is unknown in musk-
oxen. When BPAT was validated to screen for brucellosis in
other species, the sensitivities varied from 98% in reindeer
(Gall et al. 2001) to 86% in bison (Nielsen and Gall 2001)
and 77% in sheep (same subfamily muskoxen belong to;
Nielsen and Gall 2001) leading to varying percentages of
false negative results. Additionally, although the confir-
matory tests used (i.e., CFT, iELISA, cELISA) all have a
sensitivity of 100% for the detection of Brucella antibodies
for caribou (Gall et al. 2001), they were used in series and
not in parallel with BPAT; thus the overall sensitivity did
not improve. We can’t exclude, therefore, that positive sera
might have been missed in samples screened by BPAT; this
possibility is reinforced considering that Brucella antibodies
were not detected by BPAT in the serum of one muskox
that was culture-positive for B. suis biovar 4 (CB 1998;
Table 3).
With reference to the newly performed A/G iELISA,
this test has been used extensively to screen for Brucella in
muskoxen and other Arctic wildlife (Nymo et al. 2013,
2016). The A/G iELISA has been validated for Brucella
antibody detection in blood of reindeer and caribou (sen-
sitivity 100%, specificity 99.3%; Nymo et al. 2013) but not
for muskoxen. In the present study, however, we observed a
clear difference in the %P values (thus OD values) of the
blood samples that were scored as negative or positive with
A/G iELISA, which aligned with the %P of the blood
samples of the culture-positive and culture-negative
muskoxen (Table 2). Therefore, although the A/G iELISA
has not been validated for muskoxen using a conventional
methodology, the potential misclassification of the
serostatus of the samples tested with A/G iELISA due to an
inadequate cutoff value is unlikely in this study. As with
other serological methods, A/G iELISA cannot distinguish
between anti-Brucella antibodies and antibodies from
cross-reacting bacteria that share common epitopes with
Brucella spp. on the O-polysaccharide (Nymo et al. 2013).
False positives from serological cross-reactions are a major
problem for the interpretation of serological results from
wildlife, including muskoxen, yet they are difficult to assess
because little is known about co-infecting agents and their
ability to cross-react in the different species (Nymo et al.
2013). Although false-positive results due to co-infections
with cross-reacting agents cannot be excluded in this study,
we note that A/G iELISA results matched the bacteriology
results. The A/G ELISA Brucella results have also previously
been shown to be in coherence with bacteriology results in
caribou (Nymo et al. 2013).
One important challenge in this study was the use of
different sample types (FP, serum, plasma), as well as dif-
ferent time of storage and methods of storage (i.e., filter
papers only) prior testing. Contrary to BPAT-tested sam-
ples, which were tested shortly after time of collection, A/G
iELISA-tested samples were stored for different periods of
time prior to testing in 2017 (i.e., from a minimum of a few
months to a maximum of 9 years). Additionally, some filter
papers were stored frozen, while others were stored dried at
room temperature. Curry et al. (2014a) evaluated in cari-
bou and reindeer the effect of long-term storage of blood
samples and storage methods of FPs on Brucella serology
results and found comparable results to serum over a
storage period of up to 2 years. Long-term stability studies
on human serum samples archived at - 25C have also
shown that antibodies remain stable up to 25 years
(Langseth et al. 2009); however, we cannot exclude that
antibodies may deteriorate somewhat over time leading to
false negatives. In this study, such a mechanism may have
led to the underestimation of Brucella serostatus of samples
collected in the Cambridge Bay and Kugluktuk areas from
2010 onwards. As a note we report that in 2014, shortly
after sample collection, the serum of the muskox described
in Tomaselli et al. (2016) was tested at the Brucellosis
Center of Expertise, Ottawa and resulted highly positive for
Brucella antibodies with the iELISA. In 2017, within the
scope of this study, we tested the archived serum and
paired filter paper (FP stored dried at room temperature
since 2014) from that same animal with the A/G iELISA.
Three years after field collection serum and FP were still
highly positive for Brucella antibodies (see Table 3).
We were fortunate that paired FPs and sera were
available for a subset of animals. The 100% results agree-
ment obtained in paired FPs and sera indicates that FPs are
valid samples for Brucella screening by A/G iELISA for
muskoxen. These findings are consistent with what Curry
et al. (2011) reported for caribou using iELISA. For the
future, the easily implementable FP sampling can be an
asset for increasing the field surveillance capacity for Bru-
cella in harvested muskoxen. In this species, FPs might also
be promising for ELISA screening for other pathogens as
described for caribou (Curry et al. 2011; Curry et al.
2014a, b).
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The change in testing approach over the sampling
period 1989–2016 reflects the evolution in laboratory
diagnostics for Brucella serology screening. We were able to
compare the results from the A/G iELISA and BPAT testing
for a subset of sera. The agreement between the two tests
(100% in our subset of samples) makes us more confident
in the results reported in this study despite the absence of
test validation. Culture data were also invaluable for further
interpretation of the serology testing. Animals that were
culture positive for B. suis biovar 4 also were serologically
positive by A/G iELISA. In contrast, one animal was neg-
ative on BPAT but positive by culture. In this case, the
bacterium was isolated in a lymph node, but we cannot
exclude that it was an early infection in which IgG were not
yet produced. For future surveillance efforts, we suggest to
prioritize the A/G iELISA for serology screening of Brucella
in muskoxen. Combined implementation of serology with
pathological and microbiological examinations is essential
for the correct interpretation of disease status. Moreover,
standardized sampling and analytical approaches are nee-
ded to evaluate changes in Brucella seroprevalence and/or
disease spread over time and across localities.
Discussion of Results by Location
We only detected seropositive muskoxen in the Cambridge
Bay area, both on Victoria Island and on Kent peninsula
mainland. Our results suggest an increasing seroprevalence
in this area; however, we are comparing BPAT-tested
samples (1989–2001) with A/G iELISA-tested samples
(2010–2016). To consider this increase valid based on our
serology data alone, we have to assume that the tests have
similar sensitivities and specificities and that the population
tested is comparable in the two periods (i.e., same pro-
portion of adults and juveniles, males and females). Based
on available knowledge on test characteristics and sampling
strategies, we cannot confirm these assumptions, thus
limiting our confidence, based on serology data alone, that
Brucella seroprevalence has truly increased. However, the
triangulation of our serology data with historic and current
participatory epidemiology and scientific data available for
the same area provide supporting evidence that B. suis
biovar 4 might truly be increasing in muskoxen on Victoria
Island. Culture data from our study confirmed that B. suis
biovar 4 is present in Victoria Island muskoxen. Addi-
tionally, the participatory epidemiology data gathered from
Cambridge Bay harvesters align with what we would expect
in a population where B. suis biovar 4 is circulating: a
population decline with a decrease in the proportion of
young animals suggesting reproductive failure, and typical
Brucella-like syndromes such as swollen joints and limping
animals (Tomaselli et al. 2018b). Furthermore, historic
scientific information available for the Cambridge Bay area
on muskoxen and sympatric caribou also supports that
brucellosis may be increasing in this location. Blood sam-
ples from 120 muskoxen and 62 caribou of the Dolphin
and Union herd collected between 1986 and 1990 on the
southeastern Victoria Island were negative for Brucella
antibodies (Gunn et al. 1991); however, a recent serological
study of the Dolphin and Union caribou herd suggests that
Brucella is now present in this species as well (Carlsson
et al. 2019; Fig. 2). Whether the presence of B. suis biovar 4
in muskoxen on Victoria Island is associated with a spill-
over event from the seasonally sympatric Dolphin and
Union caribou herd, or if it has been circulating indepen-
dently in muskoxen, cannot be determined based on our
data. Finally, although the role of Brucella in the recent
population declines remains uncertain, it has been impli-
cated as influencing population dynamics elsewhere. For
example, in the closely monitored caribou population of
Southampton Island (Nunavut), the overall decline and
decreased pregnancy rates were temporally associated with
increasing Brucella seroprevalence (Campbell 2013). Addi-
tionally, increased Brucella seroprevalence was also found
in a declining muskox population in Alaska (Afema et al.
2017).
Participatory epidemiology data documented through
interviews of Cambridge Bay harvesters elucidated other
mechanisms that could help further explain the observed
change in demographics. These include the progressive
deterioration of the body condition status of muskoxen and
recent observation of Orf-like syndromes with orf virus
confirmed through active sampling (Tomaselli et al. 2018b,
2016). The first mechanism can have a negative impact on
pregnancy rates, while the second on calf survival. In the
Cambridge Bay area, all these mechanisms—increased
Brucella and orf virus exposure, and decline in body con-
dition status—combined with widespread and unusual
mortalities associated with Erysipelothrix rhusiopathiae
(Kutz et al. 2015; Tomaselli et al. 2018b) and harvesting
pressure may have interacted to produce the observed
population decline. Further studies, including standardized
sampling approaches and modeling, are required to
understand the potential role of Brucella in the decline of
the muskox population on Victoria Island.
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In the Ulukhaktok area, although serology was negative
on all historical samples tested, B. suis biovar 4 was isolated
from one harvested muskox in 1996; contemporary sam-
ples were not available for this study. Given our results for
the Cambridge Bay area, the detection of Brucella anti-
bodies in sympatric caribou (Carlsson et al. 2019; Fig. 2)
and the recent documentation of Brucella suis infection in
one resident of Ulukhaktok (Turvey et al. 2017), it is
possible that rangiferine brucellosis is circulating among
the muskoxen of the Ulukhaktok area. We believe it is
important to prioritize Brucella surveillance for the musk-
oxen of this area, including testing of contemporary sam-
ples and targeted participatory epidemiology studies.
We did not detect Brucella antibodies in the muskoxen
sampled near Sachs Harbour (Banks Island) and Kugluktuk
(mainland). However, given the limitations discussed for
the interpretation of the serological data and the small
sample size for the KU area, we cannot say definitely that
brucellosis is absent from those areas. For Banks Island
samples, although we cannot exclude that BPAT screening
failed to detect Brucella antibodies, we are more confident
in our results given a larger sample size and the fact sero-
logical testing was paired with veterinary postmortem
inspections of carcasses which found no evidence of bru-
cellosis (Elkin B., personal communication). On Banks
Island, muskoxen do not have contact with barren-ground
caribou (the most common hosts for the bacteria) but share
their range with the Peary caribou (Rangifer tarandus pearyi)
(Nagy et al. 1996). To date there are no reports of rangiferine
brucellosis in Peary caribou on Banks Island (Species at Risk
Committee 2012); however, there has been limited testing of
this species for Brucella (Elkin B., personal communication)
and local knowledge on brucellosis has not been docu-
mented. On the contrary, on the mainland, including the
Kugluktuk area, available data already suggest that B. suis
biovar 4 is present in muskoxen (Gates et al. 1984; Forbes
1991; Gunn et al. 1991; Fig. 1) and in sympatric barren-
ground caribou (Gunn et al. 1991; Carlsson et al. 2019). For
the future, documenting local knowledge from harvesters
from Sachs Harbour and Kugluktuk will aid in better
understanding historic and contemporary Brucella status of
muskoxen in those areas. This is of great relevance especially
for Banks Island given the continued and rapid decline of
muskoxen (Kutz et al. 2017).
CONCLUSION
Brucella suis biovar 4 is a pathogen with serious implication
in the Arctic. Our study demonstrated that B. suis biovar 4
is present in muskoxen that are commonly harvested for
food and through guided hunts on Victoria Island and the
adjacent mainland. We initiated the study in response to
local knowledge in the Cambridge Bay area that reported
increased occurrence of clinical signs and demographic
changes in muskoxen that were consistent with brucellosis.
We were able to achieve a greater understanding of Brucella
status in muskoxen in this area through the process of
triangulation of data derived by active sampling, archived
collections, and participatory epidemiology. The same level
of understanding was not possible for the other locations
where participatory epidemiology was not documented.
This study reinforces that inference of disease status by
relying on serology alone is challenging for wildlife and it
provides evidence that a transdisciplinary approach that
combines scientific and local knowledge can improve the
understanding and strengthen the surveillance capacity for
rangiferine brucellosis in the Arctic. Given the pathogenic
potential of B. suis biovar 4 for both human and wildlife
and the association of Brucella with population declines
elsewhere, it is important to strengthen the surveillance for
B. suis biovar 4 in muskoxen, understanding its epidemi-
ology and impact, through the application of standardized
Figure 2. Two caribou of the Dolphin and Union herd pho-
tographed on May 08, 2019 on the mainland close to Kent peninsula
and adjacent to Victoria Island. The caribou on the right has evident
bilateral carpal hygromas—swollen joints—especially severe on the
right leg: a typical sign of Brucella suis biovar 4 infection. This
caribou, which also appears to have a severe subcutaneous infestation
with warble fly larvae on its back, has a noticeable physiological delay
for expected seasonal changes, such as growing antlers and shedding
winter coat, compared to the caribou on the left, which appeared
healthy. Photo: Inuit harvester, Candice Pedersen (Color figure on-
line).
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sampling methods and testing combined with targeted
participatory epidemiology studies. Collaborations with
local harvesters and resource users not only will enhance
the depth and breadth of understanding of Brucella status
in local wildlife but also it will aid in implementing public
health mitigation strategies that are locally customized.
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